side effects with tirzepatide Effects: Complete Guide For 2026 Does Tirzepatide Cause Spotting? Side

This and a B-12 deficiency may damage your nerves, with or without diabetes

Eli Lilly plans to submit orforglipron GLP-1 pill data to the FDA by the end of the year for consideration of the pill for weight loss management, and for Type 2 diabetes management in early 2026

S3R drugs are those that may have an increased risk of illegal diversion or abuse

Available at: (Accessed: 5 January 2023)

In men, expect steadier morning testosterone readings, improved semen parameters, and fewer episodes of testicular discomfort

Semaglutide tablets received approval from the US Food and Drug Administration (FDA) in December 2025 and launched in the United States in January 2026, making them the first oral GLP-1 receptor agonist licensed specifically for weight management in the world